Efficacy of Transversalis Fascia Plane Block Versus Wound Infiltration in Varicoselectomy Surgery

Comparison of the Efficacy of Transversalis Fascia Plane Block and Wound Infiltration in Varicoselectomy Surgery; Randomised, Controlled Study.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05172882

Enrollment

Registered

2021-12-29

Start date

2021-11-15

Completion date

2022-04-15

Last updated

2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Transversalis Fascia Plane Block, Wound Infiltration, Varicoselectomy

Brief summary

Before surgery, patients will be divided into 2 groups as transversalis fascia plane block will be applied and skin infiltration will be applied. Post-operative analgesic procedures will be applied to patients receiving general anesthesia. Postoperative analgesic consumption and pain scores of the patients will be evaluated.

Interventions

PROCEDUREWound site infiltration

Block fluids that were prepared as 20 ml 0.25% bupivacaine before the intervention, will be applied through the upper and lower incision lips on the suprainguinal surgical site.

PROCEDURETransversalis fascia plane block

External, internal oblique, and transversus abdominis muscles will be visualized by the ultrasound device. After transversalis fascia will be seen, transversalis fascia plane block will be performed. As a block fluid 20 ml 0.25% bupivacaine will be applied.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

MALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients over the age of 18 who will undergo Varicocele operation * ASA I-II

Exclusion criteria

* Patients with allergic reaction to anesthesia and analgesia drugs to be used * Patients who did not want to voluntarily participate in the study * Severe systemic disease (kidney, liver, pulmonary, endocrine) * Substance abuse history * Chronic pain history * Psychiatric problems and communication difficulties * History of hematological problem * Patients with severe hemodynamic instability due to infection, heavy bleeding

Design outcomes

Primary

Measure	Time frame	Description
Pain Scores (0 (low)-10 (high))	1st hour	Pain will be assessed by visual analog scale scores

Secondary

Measure	Time frame	Description
Rescue analgesic consumption	Any time on postsurgical first 24 hour.	Analgesic drug consumption will be assessed

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026